Aripiprazole for the treatment of irritability associated with autism
- 27 January 2011
- journal article
- research article
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 12 (4), 635-640
- https://doi.org/10.1517/14656566.2011.557661
Abstract
Introduction: Irritability (including tantrums, aggression and moodiness) is often associated with autistic disorder. Children with autism are frequently prescribed atypical antipsychotic medications for these behaviors. Although multiple agents have been found to be effective, the safety and tolerability of each antipsychotic may be the determining factor in its selection. Areas covered: The pharmacokinetics, pharmacodynamics, safety and efficacy data on aripiprazole for the treatment of irritability associated with autism are discussed. Knowledge of the mechanism of action, advantages and disadvantages relative to other atypical antipsychotics, and an appreciation of the efficacy of aripiprazole when used to treat irritability in autism is also explored in this paper. Expert opinion: Aripiprazole may have a more favorable side-effect profile than another commonly prescribed medication, risperidone, because of its unique mechanism of action. It seems to be effective in treating irritability associated with autism, but more research is needed.Keywords
This publication has 25 references indexed in Scilit:
- Safety and Tolerability of Aripiprazole in the Treatment of Irritability Associated With Autistic Disorder in Pediatric Subjects (6–17 Years Old)The Primary Care Companion For CNS Disorders, 2011
- Line-Item Analysis of the Aberrant Behavior Checklist: Results from Two Studies of Aripiprazole in the Treatment of Irritability Associated with Autistic DisorderJournal of Child and Adolescent Psychopharmacology, 2010
- Aripiprazole in Autism Spectrum Disorders and Fragile X SyndromeNeurotherapeutics, 2010
- Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic DisorderPEDIATRICS, 2009
- Aripiprazole in Pervasive Developmental Disorder Not Otherwise Specified and Asperger's Disorder: A 14-Week, Prospective, Open-Label StudyJournal of Child and Adolescent Psychopharmacology, 2009
- Aripiprazole Monotherapy in Children and Young Adolescents with Pervasive Developmental DisordersCNS Drugs, 2009
- Plasma Pharmacokinetic Characteristics of Risperidone and Their Relationship to Saliva Concentrations in Children with Psychiatric or Neurodevelopmental DisordersClinical Therapeutics, 2007
- Pervasive Developmental Disorders in Preschool Children: Confirmation of High PrevalenceAmerican Journal of Psychiatry, 2005
- Medication Patterns in Patients with Autism: Temporal, Regional, and Demographic InfluencesJournal of Child and Adolescent Psychopharmacology, 2005
- Aripiprazole for Maladaptive Behavior in Pervasive Developmental DisordersJournal of Child and Adolescent Psychopharmacology, 2004